Aripiprazole as second-line pharmacotherapy for a heterogeneous cohort of refractory functional dizziness disorders: a pilot preliminary retrospective study - Top-Institutions - MDSpire

Aripiprazole as second-line pharmacotherapy for a heterogeneous cohort of refractory functional dizziness disorders: a pilot preliminary retrospective study

By
Fumiyuki Goto
Koichiro Wasano
June 3, 2026
0 min

Frontiers In Neurology

Share

Top Institutions in Otolaryngology

Brief introduction explaining scope and methodology.

#1

Goto ENT & Dizziness Clinic

Machida, Tokyo
Key Differentiators
- Psychiatry
- Otolaryngology
#2

University Hospital of Trieste

Trieste, Friuli Venezia Giulia
Key Differentiators
- Psychiatry
#3

Shiraz University of Medical Sciences

Shiraz, Fars
Key Differentiators
- Psychiatry
#4

University Medical Center

Unknown, Japan
Key Differentiators
- Psychiatry
#5

Medical University of Gdańsk

Gdańsk, Pomeranian Voivodeship
Key Differentiators
- Psychiatry